Senarai ester estrogen

Daripada Wikipedia, ensiklopedia bebas.
Estradiol, estrogen asas bagi kebanyakan ester estrogen.

Ini ialah senarai ester estrogen atau prodrug ester estrogen. Ia termasuk ester serta eter bagi estrogen steroid seperti estradiol, estron dan estriol, dan estrogen bukan steroid seperti stilbestrol, sebagai contoh, dietilstilbestrol dan heksestrol.

Esters estrogen steroid[sunting | sunting sumber]

Ester estradiol[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Banyak ester estradiol telah dipasarkan termasuk ester utama di bawah:[1][2]

Ester kurang lazim di bawah juga dipasarkan:[1][2]

Ester mustard nitrogen estradiol di bawah ialah agen antineoplastik sitostatik, dan tidak pernah dipasarkan:[1][2]

Tidak pernah dipasarkan[sunting | sunting sumber]

Sebilangan ester estradiol yang tidak pernah dipasarkan termasuk:[2]

Ester mustard nitrogen estradiol di bawah ialah agen antineoplastik sitostatik, dan tidak pernah dipasarkan:[2]

Ester estron[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Ester estron yang dipasarkan termasuk:[1][2]

Tidak pernah dipasarkan[sunting | sunting sumber]

Ester estron utama lain yang tidak dipasarkan termasuk:

Ester estriol[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Ester estriol yang dipasarkan termasuk:[1][2]

Tidak pernah dipasarkan[sunting | sunting sumber]

Ester estriol di bawah tidak pernah dipasarkan:

Ester etinilestradiol[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Ester ethinilestradiol di bawah telah dipasarkan:[1][2]

Tidak pernah dipasarkan[sunting | sunting sumber]

Esters esterogen steroid lain[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Ester estrogen lain di bawah telah dipasarkan:[1]

Eter estrogen steroid[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Sebilangan eter estrogen dipasarkan, termasuk:[22][1]

Tidak pernah dipasarkan[sunting | sunting sumber]

Sebilangan eter estrogen ketar juga tidak pernah dipasarkan, termasuk:[22]

Ester estrogen bukan steroid[sunting | sunting sumber]

Ester dietilstilbestrol[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Ester utama dietilstilbestrol termasuk:

  • Dietilstilbestrol dipropionat (Agostilben, Biokeral, Clinestrol, Cyclen, Estilbin, Estril, Neobenzoestrol, Orestol, Oroestrol, Ostregenin, Prostilbene, Stilbestriol DP, Stilboestrolum Dipropionicum, Stilboestrol, Synestrin, Willestrol)
  • Fosfestrol (dietilstilbestrol difosfat) (Honvan, Difostilben, Fosfostilben, Fostrolin, Stilbol, Stilphostrol, Vagestrol)

Ester dietilstilbestrol yang kurang lazim termasuk:

Tidak pernah dipasarkan[sunting | sunting sumber]

Serta ester mustard nitrogen berikut:

  • ICI-85966 (Stilbostat; dietilstilbestrol bis(di(2-kloroetil)karbamat))

Ester heksestrol[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Tidak pernah dipasarkan[sunting | sunting sumber]

Ester heksestrol mustard nitrogen berikut tidak pernah dipasarkan:

  • Fenestrol (fenestrol; heksestrol bis[4-[bis(2-kloroetil)amino]fenilasetat)

Ester estrogen bukan steroid lain[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

Eter estrogen bukan steroid[sunting | sunting sumber]

Dietilstilbestrol[sunting | sunting sumber]

Dipasarkan[sunting | sunting sumber]

  • Dietilstilbestrol monobenzil eter (benzelstilbestrol) (Monozol, Hypantin, Pituitrope)
  • Dimestrol (dianisilheksena, dietilstilbestrol dimetil eter, dimetoksidietilstilbestrol) (Depot-Ostromon, Synthila)
  • Mestilbol (dietilstilbestrol monometil eter) (Monomestro atau Monomestrol)

Lihat juga[sunting | sunting sumber]

Rujukan[sunting | sunting sumber]

  1. ^ a b c d e f g h IndexNominum2000. Tailor & Francis US. 2000. m/s. 404. ISBN 978-3-88763-075-1. Dicapai pada 29 May 2012.
  2. ^ a b c d e f g h A. D. Roberts (1991). Dictionary of Steroids: Chemical Data, Structures, and Bibliographies. CRC Press. m/s. 415. ISBN 978-0-412-27060-4. Dicapai pada 20 May 2012.
  3. ^ Ferin, J. (1952). "Relative duration of action of natural and synthetic estrogens administered parenterally in women with estrogen deficiency". The Journal of Clinical Endocrinology & Metabolism. 12 (1): 28–35. doi:10.1210/jcem-12-1-28. ISSN 0021-972X. PMID 14907837.
  4. ^ "R&D Research". Diarkibkan daripada yang asal pada 2017-09-29. Dicapai pada 2018-06-25.
  5. ^ Elger W, Wyrwa R, Ahmed G, Meece F, Nair HB, Santhamma B, Killeen Z, Schneider B, Meister R, Schubert H, Nickisch K (January 2017). "Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions". J. Steroid Biochem. Mol. Biol. 165 (Pt B): 305–311. doi:10.1016/j.jsbmb.2016.07.008. PMID 27449818. S2CID 26650319.
  6. ^ Ahmed G, Elger W, Meece F, Nair HB, Schneider B, Wyrwa R, Nickisch K (October 2017). "A prodrug design for improved oral absorption and reduced hepatic interaction". Bioorg. Med. Chem. 25 (20): 5569–5575. doi:10.1016/j.bmc.2017.08.027. PMID 28886996.
  7. ^ Nickisch, K., Santhamma, B., Ahmed, G., Meece, F., Elger, W., Wyrwa, R., & Nair, H. (2017). U.S. Patent No. 9,745,338. Washington, DC: U.S. Patent and Trademark Office. https://patents.google.com/patent/US9745338B2/en
  8. ^ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. m/s. 388–. ISBN 978-92-832-1291-1.
  9. ^ Vizzone, A.; Murari, G. (November 1966). "[Estradiol esters (3-monobenzoate and 3-benzoate-17-beta-acetat) in the therapy of the surgical menopause syndrome. Experimental and clinical results]". Quaderni di Clinica Ostetrica e Ginecologica. 21 (11): 779–790. PMID 5999221.
  10. ^ a b c Hussain MA, Aungst BJ, Shefter E (January 1988). "Prodrugs for improved oral beta-estradiol bioavailability". Pharm. Res. 5 (1): 44–7. doi:10.1023/A:1015863412137. PMID 3244608. S2CID 7308414.
  11. ^ a b c Lokind, Kenneth B.; Lorenzen, Finn Hjort; Bundgaard, Hans (1991). "Oral bioavailability of 17β-estradiol and various ester prodrugs in the rat". International Journal of Pharmaceutics. 76 (1–2): 177–182. doi:10.1016/0378-5173(91)90356-S. ISSN 0378-5173.
  12. ^ a b Falconi G, Galletti F, Celasco G, Gardi R (November 1972). "Oral long-lasting estrogenic activity of estradiol 3-benzoate 17-cyclooctenil ether". Steroids. 20 (5): 627–38. doi:10.1016/0039-128X(72)90020-7. PMID 4654978.
  13. ^ Galletti F, Gardi R (April 1974). "Effect of two orally active estradiol derivatives on sulfobromphthalein retention in rats". Pharmacol Res Commun. 6 (2): 135–45. doi:10.1016/s0031-6989(74)80021-4. PMID 4438394.
  14. ^ Ralph I. Dorfman (5 December 2016). Steroidal Activity in Experimental Animals and Man. Elsevier Science. m/s. 36–. ISBN 978-1-4832-7299-3.
  15. ^ Janocko, Laura; Larner, Janice M.; Hochberg, Richard B. (1984). "The Interaction of C-17 Esters of Estradiol with the Estrogen Receptor*". Endocrinology. 114 (4): 1180–1186. doi:10.1210/endo-114-4-1180. ISSN 0013-7227. PMID 6705734.
  16. ^ Dahlgren E, Crona N, Janson PO, Samsioe G (1985). "Oral replacement with estradiol-cyclooctil acetate: a new estradiol analogue. Effects on serum lipids, proteins, gonadotrophins, estrogens and uterine endometrial morphology". Gynecol. Obstet. Invest. 20 (2): 84–90. doi:10.1159/000298978. PMID 3932144.
  17. ^ Luisi M, Kicovic PM, Alicicco E, Franchi F (1978). "Effects of estradiol decanoate in ovariectomized women". J. Endocrinol. Invest. 1 (2): 101–6. doi:10.1007/BF03350355. PMID 755846. S2CID 38187367.
  18. ^ a b Gleason CH, Parker JM (1959). "The duration of activity of the benziloil hidrazones of testosterone-17-heptanoate, estrone-3-heptanoate and 17α-hidroksi-progesterone-17-heptanoate". Endocrinology. 65 (3): 508–511. doi:10.1210/endo-65-3-508. ISSN 0013-7227. PMID 13828402.
  19. ^ George W.A Milne (8 May 2018). Drugs: Synonyms and Properties: Synonyms and Properties. Tailor & Francis. m/s. 1406–. ISBN 978-1-351-78989-9.
  20. ^ a b Elger W, Palme HJ, Schwarz S (April 1998). "Novel oestrogen sulfamates: a new approach to oral hormone therapy". Expert Opin Investig Drugs. 7 (4): 575–89. doi:10.1517/13543784.7.4.575. PMID 15991994.
  21. ^ Elger W, Schwarz S, Hedden A, Reddersen G, Schneider B (December 1995). "Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application". J. Steroid Biochem. Mol. Biol. 55 (3–4): 395–403. doi:10.1016/0960-0760(95)00214-6. PMID 8541236. S2CID 31312.
  22. ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ISBN 978-1-4757-2085-3.
  23. ^ Patel JU, Prankerd RJ, Sloan KB (October 1994). "A prodrug approach to increasing the oral potency of a phenolic drug. 1. Synthesis, characterization, and stability of an O-(imidomethil) derivative of 17 beta-estradiol". J Pharm Sci. 83 (10): 1477–81. doi:10.1002/jps.2600831022. PMID 7884673.
  24. ^ Patel J, Katovich MJ, Sloan KB, Curry SH, Prankerd RJ (February 1995). "A prodrug approach to increasing the oral potency of a phenolic drug. Part 2. Pharmacodynamics and preliminary bioavailability of an orally administered O-(imidomethil) derivative of 17 beta-estradiol". J Pharm Sci. 84 (2): 174–8. doi:10.1002/jps.2600840210. PMID 7738796.
  25. ^ a b Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. m/s. 1395–. ISBN 978-1-60913-345-0.

Templat:Estradiol